5-(Morpholinomethyl)-2-thiopheneboronic acid pinacol ester
Product Information
Molecular Formula
C15H24BNO3S
Molecular Weight
309.23
Description
5-(Morpholinomethyl)-2-thiopheneboronic acid pinacol ester is a remarkable biomedicine compound renowned for its multifaceted therapeutic applications and has garnered substantial attention in the realm of disease management. Famed as a potential inhibitor for specific enzymes, it exhibits promising efficacy in combatting an array of cancers and inflammatory afflictions.
Synonyms
4-[[5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-thienyl]methyl]-morpholine
IUPAC Name
4-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophen-2-yl]methyl]morpholine
SMILES
B1(OC(C(O1)(C)C)(C)C)C2=CC=C(S2)CN3CCOCC3
InChI
InChI=1S/C15H24BNO3S/c1-14(2)15(3,4)20-16(19-14)13-6-5-12(21-13)11-17-7-9-18-10-8-17/h5-6H,7-11H2,1-4H3
InChI Key
CNLWVADWZRQAFZ-UHFFFAOYSA-N
Melting Point
91-96 °C
Flash Point
Not applicable
Purity
95%
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
5
Rotatable Bond Count
3
Exact Mass
309.1569950 g/mol
Monoisotopic Mass
309.1569950 g/mol
Topological Polar Surface Area
59.2Ų
Heavy Atom Count
21
Formal Charge
0
Complexity
358
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2021262684-A1 | METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION | 2020-06-22 |
| CN-113164476-A | Small molecule inhibitor of DYRK1/CLK and application thereof | 2018-09-28 |
| US-2022041590-A1 | Small molecule inhibitors of dyrk/clk and uses thereof | 2018-09-28 |
| US-2020039989-A1 | Small molecule inhibitors of dyrk/clk and uses thereof | 2018-03-01 |
| WO-2019169306-A1 | Compounds, compositions, and methods for suppressing toxic endoplasmic reticulum stress | 2018-03-01 |
| AU-2019226571-A1 | Compounds, compositions, and methods for suppressing toxic endoplasmic reticulum stress | 2018-03-01 |
| CA-3092828-A1 | Compounds, compositions, and methods for suppressing toxic endoplasmic reticulum stress | 2018-03-01 |
| EP-3759072-A1 | Compounds, compositions, and methods for suppressing toxic endoplasmic reticulum stress | 2018-03-01 |
| US-2021040091-A1 | Compounds, compositions, and methods for suppressing toxic endoplasmic reticulum stress | 2018-03-01 |
| JP-2021518856-A | Compounds, compositions, and methods for controlling toxic endoplasmic reticulum stress | 2018-03-01 |
